S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/RTW Investments/Q4 2025

RTW Investments

Period: Q4 2025 · Filed: 2026-02-17
View on SEC EDGAR
AUM
$9.98B
Total portfolio value
Positions
91
Reported securities
Top Holding
MDGL
11.6% $1.16B
QoQ Changes
+8 / -8
new · exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings — not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares — not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with ≥$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2026-02-17) shown is the underlying stock price movement — not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
MDGLMADRIGAL PHARMACEUTICALS INC$1.16B11.63%$582.34$528.10-9.3%
11.6%
INSMINSMED INC$842.9M8.44%$174.04$111.60-35.9%
8.4%
PTCTPTC THERAPEUTICS INC$588.4M5.89%$75.96$83.31+9.7%
5.9%
ARGXARGENX SE$566.4M5.67%$840.95$939.68+11.7%
5.7%
PTGXPROTAGONIST THERAPEUTICS INC$441.9M4.43%$87.34$131.62+50.7%
4.4%
NTRANATERA INC$343.6M3.44%$229.09$279.32+21.9%
3.4%
RDNTRADNET INC$281.0M2.81%$71.35$68.75-3.6%
2.8%
TARSTARSUS PHARMACEUTICALS INC$273.1M2.74%$81.88$65.44-20.1%
2.7%
COGTCOGENT BIOSCIENCES INC$269.7M2.70%$35.52$38.69+8.9%
2.7%
PENPENUMBRA INC$269.4M2.70%$310.91$318.57+2.5%
2.7%
IRTCIRHYTHM TECHNOLOGIES INC$209.7M2.10%$177.44$126.48-28.7%
2.1%
APGEAPOGEE THERAPEUTICS INC$204.7M2.05%$75.48$132.91+76.1%
2.0%
APLSAPELLIS PHARMACEUTICALS INC$192.6M1.93%$25.12
1.9%
ACADACADIA PHARMACEUTICALS INC$190.8M1.91%$26.71$25.97-2.8%
1.9%
ESTAESTABLISHMENT LABS HLDGS INC$188.7M1.89%$72.88$89.25+22.5%
1.9%
STOKSTOKE THERAPEUTICS INC$176.1M1.76%$31.74$32.70+3.0%
1.8%
RGENREPLIGEN CORP$174.3M1.75%$163.86$142.40-13.1%
1.8%
CYTKCYTOKINETICS INC$172.9M1.73%$63.54$86.49+36.1%
1.7%
IMCRIMMUNOCORE HLDGS PLC$169.0M1.69%$34.71$32.50-6.4%
1.7%
AXSMAXSOME THERAPEUTICS INC$162.2M1.62%$182.64$244.31+33.8%
1.6%
GHGUARDANT HEALTH INC$151.3M1.52%$102.14$167.98+64.5%
1.5%
NBIXNEUROCRINE BIOSCIENCES INC$150.6M1.51%$141.83$174.26+22.9%
1.5%
SYRESPYRE THERAPEUTICS INC$136.7M1.37%$32.76$86.63+164.4%
1.4%
ZLABZAI LAB LTD$122.8M1.23%$17.64$19.12+8.4%
1.2%
IMTXIMMATICS N.V$120.0M1.20%$10.50$9.95-5.2%
1.2%
BLTEBELITE BIO INC$114.4M1.15%$159.96$146.63-8.3%
1.1%
URGNUROGEN PHARMA LTD$106.4M1.07%$23.42$38.02+62.3%
1.1%
XNCRXENCOR INC$103.8M1.04%$15.31$15.00-2.0%
1.0%
PODDINSULET CORP$92.3M0.92%$284.24$164.48-42.1%
0.9%
TSHATAYSHA GENE THERAPIES INC$90.2M0.90%$5.50$6.53+18.7%
0.9%

Quarter-on-Quarter Activity

Q4 2025 vs. Q3 2025

New Positions (8)

TickerIssuerNotionalSince Filing
IRTCIRHYTHM TECHNOLOGIES INC$209.7M-28.7%
APLSAPELLIS PHARMACEUTICALS INC$192.6M
RGENREPLIGEN CORP$174.3M-13.1%
PODDINSULET CORP$92.3M-42.1%
CSTLCASTLE BIOSCIENCES INC$82.3M
IMVTIMMUNOVANT INC$80.8M
CELCCELCUITY INC$54.9M
KODKODIAK SCIENCES INC$41.6M

Exited Positions (8)

TickerIssuerNotional
RNAMAVIDITY BIOSCIENCES INC$495.5M
AKROAKERO THERAPEUTICS INC$260.1M
MRUSMERUS N V$190.7M
DGXQUEST DIAGNOSTICS INC$47.6M
LENZLENZ THERAPEUTICS INC$40.2M
DYNDYNE THERAPEUTICS INC$36.6M
ABVXABIVAX SA$29.7M
GEHCGE HEALTHCARE TECHNOLOGIES I$29.6M

Increased (8)

TickerIssuerNotionalShares ΔSince Filing
ZLABZAI LAB LTD$45.1M+203.7%+8.4%
ALURALLURION TECHNOLOGIES INC$2.0M+131.7%
BLTEBELITE BIO INC$91.3M+128.9%-8.3%
COGTCOGENT BIOSCIENCES INC$219.9M+119.0%+8.9%
INSMINSMED INC$398.6M+57.0%-35.9%
CRNXCRINETICS PHARMACEUTICALS IN$26.6M+54.9%
WVEWAVE LIFE SCIENCES LTD$16.4M+50.0%
RDNTRADNET INC$66.4M+39.9%-3.6%

Trimmed (8)

TickerIssuerNotionalShares ΔSince Filing
CRVSCORVUS PHARMACEUTICALS INC$-16.3M-83.3%
XGNEXAGEN INC$-13.8M-53.4%
SYKSTRYKER CORPORATION$-95.0M-50.0%
ISRGINTUITIVE SURGICAL INC$-33.2M-50.0%
TSHATAYSHA GENE THERAPIES INC$10.6M-32.7%+18.7%
NTRANATERA INC$21.7M-25.0%+21.9%
BBNXBETA BIONICS INC$10.6M-24.2%
CNTACENTESSA PHARMACEUTICALS PLC$-10.8M-21.9%
Back to Hedge Funds